Exercise 201tl/rest 99tcm-tetrofosmin myocardial perfusion imaging: A convenient protocol for the assessment of coronary disease

Nuclear Medicine Communications

Volumn 17, Issue 4, 1996, Pages 317-324

  Woldman, S ^a   McQuiston, A ^a   Ng, A ^a   Martin, W ^a   Hutton, I ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM; TECHNETIUM 99M; TETROFOSMIN; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; EVALUATION; EXERCISE TEST; FEMALE; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; ANGIOGRAPHY; CLINICAL ARTICLE; ISCHEMIC HEART DISEASE; SCINTIGRAPHY; STRESS;

ADULT; AGED; CLINICAL PROTOCOLS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EVALUATION STUDIES; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES;

EID: 0029665788     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199604000-00159     Document Type: Article

References (21)

1. Sonnemaker RE, Floyd JL, Nusnowitz ML, Bode RF, Spicer A, Waliszewski JA. Single injection thallium-201 stress and redistribution myocardial perfusion imaging: Comparison with stress electrocardiography and coronary arteriography. Radiology 1979; 131: 199-203.
2. Verani MS, Marcus ML, Razzak MA, Ehrhardt JC. Sensitivity and specificity of thallium 201 perfusion scintigrams in the evaluation of coronary artery disease. J Nucl Med 1978; 19: 773-782.
3. Okada RD, Boucher CA, Strauss HW, Pohost GM. Exercise radionuclide imaging approaches to coronary artery disease. Am J Cardiol 1980; 46: 1188-1204.
4. Beller GA. Myocardial perfusion imaging with thallium- 201. J Nucl Med 1994; 35: 674-680.
5. Mahmarian JJ, Verani MS. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease. Am J Cardiol 1991; 67: 2D-11D.
6. Diamond GA. How accurate is SPECT thallium scintigraphy. J Am Coll Cardiol 1990; 16: 1017-1021.
7. Martin W, Tweddel AC, McGhie AI, Hutton I. Gated thallium scintigraphy in patients with coronary artery disease: An improved planar imaging technique. Clin Phys Physiol Meas 1987; 8: 343-354.
8. Tamaki N, Yonekura Y, Yamashita K et al Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. Am J Cardiol 1988; 65: 65-73.
9. Brunken RC, Kottou S, Nienaber CA et al. PET detection of viable tissue in myocardial segments with persistent defects at T1 201 SPECT. Radiology 1989; 172: 65-73.
10. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87: 2-20.
11. Kaul S, Boucher CA, Okada RD, Newell JB, Strauss HW, Pohost GM. Source of variability in the radionuclide angiographic assessment of ejection fraction: A comparison of first pass and gated equilibrium techniques. Am J Cardiol 1984; 53: 823-828.
12. Burow RD, Strauss HW, Singleton R, Pond M, Rehn T, Bailey IK, Griffith LC, Nickoloff E, Pitt B. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging: Comparison to contrast angiography. Circulation 1977; 56: 1024-1028.
13. Dymond DS, Elliott A, Stone D, Hendrix G, Spurrell R. Factors that affect reproducibility of measurements of left ventricular function from first pass radionuclide ventriculograms. Circulation 1982: 65: 311-322.
14. Bonow RO, Dilsizian V. Thallium 201 and technetium 99m sestamibi for assessing viable myocardium. J Nucl Med 1992; 33: 815-818.
15. Higley B, Smith FW, Smith T, Gemmell H, Gupta PD, Guozdanovic DU, Graham D, Hinge D, Davidson J, Lahiri A. Technetium 99m 1,2 bis bis[2 ethoxyethyll phosphino] ethane: Human biodistribution dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
16. Takahashi N, Tamaki N, Tadamura E, Kawamoto M. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin. J Nucl Cardiol 1994; 1: 317-324.
17. Weinmann P, Foult J, Le Guludec D, Tamgac F, Rechtman D et al. Dual-isotope myocardial imaging: Feasibility, advantages and limitations. Eur J Nucl Med 1994; 21: 212-215.
18. Zaret BL, Rigo P, Wackers FJT, Hendel RC, Broat SH, Iskandrian AS, Sridhara BS, Jain D, Itti R, Serafini A, Goris ML, Lahiri A. Myocardial perfusion imaging with 99m technetium tetrofosmin: Comparison to 201 T1 imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319.
19. Nakajima K, Tahi J, Shuhi N, Bunko M, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium 99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
20. Leppo J, Yipintsoi T, Blankstein R, Bontemps R, Freeman LM, Zohman L, Scheuer J. Thallium-201 myocardial scintigraphy in patients with triple vessel disease and ischemic exercise tests. Circulation 1979; 59: 714-721.
21. Wainwright RJ. Scintigraphic anatomy of coronary artery disease in digital thallium-201 myocardial images. Br Heart J 1981; 46: 465-177.